TRA-RIA: Transradial Access for Ruptured Intracranial Aneurysms Embolization

Sponsor
The First Affiliated Hospital with Nanjing Medical University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05851274
Collaborator
(none)
242
1
2
12.7
19

Study Details

Study Description

Brief Summary

The goal of this clinical trail is to compare the difference between transradial access (TRA) and transfemoral access(TFA) for ruptured intracranial aneurysms embolization. The main question it aims to answer is: whether is TRA not inferior to TFA? In the experimental group, the transradial access (TRA) was used, which was to puncture the radial artery and insert a radial sheath to establish a surgical pathway for embolization of the aneurysm; In the control group, transfemoral access (TFA) was used to embolize the aneurysms, which was to puncture the femoral artery and insert the femoral sheath to establish a surgical pathway for embolizing the aneurysms.The two groups of patients received an oral loading dose of aspirin (300mg) plus clopidogrel (300mg) on the day of surgery, while patients who were unable to take orally were given nasal feeding. During the operation, systemic heparinization was performed with a starting dose of 75U/kg intravenous injection, and the injection was halved every 1h until 1000U. After the operation, protamine neutralizing heparin (1mg protamine neutralizing 100U heparin) was used.

Condition or Disease Intervention/Treatment Phase
  • Procedure: transradial access
  • Procedure: Transfemoral access
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
242 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
In the experimental group, the transradial access (TRA) was used, which was to puncture the radial artery and insert a radial sheath to establish a surgical pathway for embolization of the aneurysm; In the control group, transfemoral access (TFA) was used to embolize the aneurysms, which was to puncture the femoral artery and insert the femoral sheath to establish a surgical pathway for embolizing the aneurysm.In the experimental group, the transradial access (TRA) was used, which was to puncture the radial artery and insert a radial sheath to establish a surgical pathway for embolization of the aneurysm; In the control group, transfemoral access (TFA) was used to embolize the aneurysms, which was to puncture the femoral artery and insert the femoral sheath to establish a surgical pathway for embolizing the aneurysm.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Transradial Access for Ruptured Intracranial Aneurysms Embolization--A Multicentre, Randomised, Open-label,Non-inferiority Trial
Anticipated Study Start Date :
May 10, 2023
Anticipated Primary Completion Date :
Apr 30, 2024
Anticipated Study Completion Date :
May 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Transradial access

In this group, the transradial access (TRA) was used, which was to puncture the radial artery and insert a radial sheath to establish a surgical pathway for embolization of the aneurysm.

Procedure: transradial access
In this group, the transradial access (TRA) was used, which was to puncture the radial artery and insert a radial sheath to establish a surgical pathway for embolization of the aneurysm

Active Comparator: Transfemoral access

In this group, transfemoral access (TFA) was used to embolize the aneurysms, which was to puncture the femoral artery and insert the femoral sheath to establish a surgical pathway for embolizing the aneurysm.

Procedure: Transfemoral access
In this group, transfemoral access (TFA) was used to embolize the aneurysms, which was to puncture the femoral artery and insert the femoral sheath to establish a surgical pathway for embolizing the aneurysm.

Outcome Measures

Primary Outcome Measures

  1. The success rate of operation [during the procedure]

    The success rate of operation

Secondary Outcome Measures

  1. Incidence of ischemic events [immediately after the procedure]

    Incidence of ischemic events

  2. Incidence of hemorrhage events [immediately after the procedure]

    Incidence of hemorrhage events

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. The age is between 18 and 75 years old.

  2. Receiving interventional embolization treatment for intracranial aneurysms.

  3. CT scan of the skull shows subarachnoid hemorrhage, and CTA or DSA of the skull shows the presence of an intracranial aneurysm, and it is determined to be aneurysm-related subarachnoid hemorrhage after evaluation by a neurosurgical specialist.

  4. At least one side of the bilateral radial arteries can be used to establish surgical access.

  5. Evaluation of radial artery patency: Barbeau test type A-C .

  6. Hunt-Hess grade 1-3, Glasgow coma score ≥ 8.

  7. Agreed to participate in this study and willing to cooperate with follow-up. -

Exclusion Criteria:
  1. Preoperative upper limb ultrasound or DSA showed radial artery spasm and arteriovenous fistula.

  2. Artery CTA or DSA showed vascular anatomical abnormalities such as axillary artery occlusion, and acute angle between the left common carotid artery and the subclavian artery, which may affect the operation.

  3. The patient's condition is serious and may die or remain in a coma after surgery, as assessed by a specialist.

  4. Received radial or femoral artery puncture examination or treatment within 1 month.

  5. The patient refused to participate in the study or cooperate with follow-up.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jiangsu Province Hospital Nanjing China

Sponsors and Collaborators

  • The First Affiliated Hospital with Nanjing Medical University

Investigators

  • Principal Investigator: Hua L Lu Hua, The First Affiliated Hospital with Nanjing Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lu Hua, Professor, The First Affiliated Hospital with Nanjing Medical University
ClinicalTrials.gov Identifier:
NCT05851274
Other Study ID Numbers:
  • TRA-RIA
First Posted:
May 9, 2023
Last Update Posted:
May 9, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Lu Hua, Professor, The First Affiliated Hospital with Nanjing Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 9, 2023